Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination | Zendy

Sherif F. Hendawy | Zendy; Hanan E. Samaha | Zendy; Mohamed Elkholy | Zendy

Open Access

Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination

Author(s) -

Sherif F. Hendawy,

Hanan E. Samaha,

Mohamed Elkholy

Publication year - 2011

Publication title -

clinical medicine insights reproductive health

Language(s) - English

Resource type - Journals

ISSN - 1179-5581

DOI - 10.4137/cmrh.s6598

Subject(s) - letrozole , ovulation induction , medicine , polycystic ovary , ovulation , anovulation , infertility , gynecology , insemination , pregnancy , endocrinology , andrology , biology , hormone , insulin , tamoxifen , sperm , insulin resistance , genetics , cancer , breast cancer

Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women in the reproductive age group, and is one of the most common causes of hyperandrogenic anovulatory infertility. The aromatase inhibitor, letrozole, has been used for induction of ovulation. The purpose of this study was to compare the effects of letrozole and clomiphene citrate in induction of ovulation among patients with PCOS undergoing intrauterine insemination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research